Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2022
Current Systemic Treatments for the Hereditary Cancer Syndromes: Drug Development in Light of Genomic DefectsElshad Hasanov, Isabel Pimentel, Mara Cruellas, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 28, 2025
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genesHéctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 28, 2025
Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genesHéctor Carlos García-Díaz, María Larrosa-Garcia, Javier Gómez-Alonso, et al.
Frontiers in Oncology|October 3, 2022
Genetic and functional homologous repair deficiency as biomarkers for platinum sensitivity in TNBC: A case reportDiego Gomez-Puerto, Alba Llop-Guevara, Mara Cruellas, et al.
JCO Precision Oncology|March 21, 2024
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency TestingAlejandra Rezqallah, Sara Torres-Esquius, Alba Llop-Guevara, et al.
Frontiers in Oncology|October 29, 2020
Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy EfficacyMaitane Ocáriz-Díez, Mara Cruellas, Marta Gascón, et al.
Cells|June 26, 2020
Intratumoral Versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?Marta Gascón, Dolores Isla, Mara Cruellas, et al.
Familial Cancer|July 5, 2022
A case of Rothmund-Thomson syndrome originally thought to be a case of Bloom syndromeDavid Humberto Marmolejo Castañeda, Mara Cruellas Lapeña, Estela Carrasco López, et al.
Infection and Immunity|February 2, 2021
How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A ReviewMara Cruellas, Alfonso Yubero, María Zapata, et al.
Breast (Edinburgh, Scotland)|March 16, 2025
Identifying germline pathogenic variants in breast cancer using tumor sequencingMara Cruellas, Andri Papakonstantinou, Adrià López-Fernández, et al.
Pageof 3